Therapeutic Applications of Catalytic Antisense RNAs (Ribozymes)
- 28 September 2007
- book chapter
- Published by Wiley
- Vol. 209, 195-206
- https://doi.org/10.1002/9780470515396.ch14
Abstract
Ribozymes have progressed from an intriguing subject of scientific study to therapeutic agents for the potential treatment of a fatal and devastating viral infection. Despite this rapid road to clinical trials, there are many unexplored avenues that should be examined to improve the intracellular effectiveness of ribozymes. Since ribozymes are RNA molecules, the cellular rules governing RNA partitioning and stability can be applied to these molecules to make them more effective therapeutic agents. Future, successful therapeutic ribozyme applications will depend upon increasing our knowledge of RNA metabolism and movement, and applying this knowledge to the design of ribozymes. This chapter discusses experimental approaches towards this goal as well as recent progress in the application of a pair of hammerhead ribozymes for the clinical treatment of HIV1 infection.Keywords
This publication has 31 references indexed in Scilit:
- HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5Nature, 1996
- Controlled, targeted, intracellular expression of ribozymes: Progress and problemsTrends in Biotechnology, 1995
- The internal equilibrium of the hammerhead ribozyme reactionBiochemistry, 1995
- Priming of HIV replication by tRNALys3: role of reverse transcriptaseTrends in Biochemical Sciences, 1994
- A Kinetic and Thermodynamic Framework for the Hammerhead Ribozyme ReactionBiochemistry, 1994
- Tethering Ribozymes to a Retroviral Packaging Signal for Destruction of Viral RNAScience, 1993
- Multifactorial Nature of Human Immunodeficiency Virus Disease: Implications for TherapyScience, 1993
- Protein Enhancement of Hammerhead Ribozyme CatalysisScience, 1993
- hnRNP PROTEINS AND THE BIOGENESIS OF mRNAAnnual Review of Biochemistry, 1993
- Ribozyme engineeringCurrent Opinion in Structural Biology, 1992